Logo image of PIII

P3 HEALTH PARTNERS INC (PIII) Stock Fundamental Analysis

NASDAQ:PIII - Nasdaq - US7444132044 - Common Stock - Currency: USD

7.42  +0.12 (+1.64%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PIII. PIII was compared to 103 industry peers in the Health Care Providers & Services industry. PIII may be in some trouble as it scores bad on both profitability and health. PIII is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PIII had negative earnings in the past year.
In the past year PIII has reported a negative cash flow from operations.
In the past 5 years PIII always reported negative net income.
In the past 5 years PIII always reported negative operating cash flow.
PIII Yearly Net Income VS EBIT VS OCF VS FCFPIII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

PIII has a Return On Assets of -17.56%. This is amonst the worse of the industry: PIII underperforms 83.50% of its industry peers.
PIII's Return On Equity of -217.60% is on the low side compared to the rest of the industry. PIII is outperformed by 78.64% of its industry peers.
Industry RankSector Rank
ROA -17.56%
ROE -217.6%
ROIC N/A
ROA(3y)-18.29%
ROA(5y)-20.52%
ROE(3y)-1599.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PIII Yearly ROA, ROE, ROICPIII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

PIII does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PIII Yearly Profit, Operating, Gross MarginsPIII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

More info and screens

0

2. Health

2.1 Basic Checks

PIII does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PIII has more shares outstanding
PIII has more shares outstanding than it did 5 years ago.
PIII has a worse debt/assets ratio than last year.
PIII Yearly Shares OutstandingPIII Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
PIII Yearly Total Debt VS Total AssetsPIII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of -0.77, we must say that PIII is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.77, PIII is doing worse than 82.52% of the companies in the same industry.
A Debt/Equity ratio of 1.69 is on the high side and indicates that PIII has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.69, PIII is doing worse than 72.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACC10.68%
PIII Yearly LT Debt VS Equity VS FCFPIII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

PIII has a Current Ratio of 0.38. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.38, PIII is not doing good in the industry: 93.20% of the companies in the same industry are doing better.
PIII has a Quick Ratio of 0.38. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
PIII has a Quick ratio of 0.38. This is amonst the worse of the industry: PIII underperforms 92.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
PIII Yearly Current Assets VS Current LiabilitesPIII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for PIII have decreased strongly by -51.80% in the last year.
Looking at the last year, PIII shows a quite strong growth in Revenue. The Revenue has grown by 9.78% in the last year.
Measured over the past years, PIII shows a very strong growth in Revenue. The Revenue has been growing by 59.38% on average per year.
EPS 1Y (TTM)-51.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.5%
Revenue 1Y (TTM)9.78%
Revenue growth 3Y33.03%
Revenue growth 5Y59.38%
Sales Q2Q%-3.93%

3.2 Future

Based on estimates for the next years, PIII will show a very strong growth in Earnings Per Share. The EPS will grow by 26.06% on average per year.
The Revenue is expected to grow by 1.77% on average over the next years.
EPS Next Y64.09%
EPS Next 2Y37.76%
EPS Next 3Y26.06%
EPS Next 5YN/A
Revenue Next Year-4.81%
Revenue Next 2Y1.36%
Revenue Next 3Y1.77%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PIII Yearly Revenue VS EstimatesPIII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
PIII Yearly EPS VS EstimatesPIII Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -50 -100 -150 -200 -250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PIII. In the last year negative earnings were reported.
Also next year PIII is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PIII Price Earnings VS Forward Price EarningsPIII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PIII Per share dataPIII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150 200

4.3 Compensation for Growth

A more expensive valuation may be justified as PIII's earnings are expected to grow with 26.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.76%
EPS Next 3Y26.06%

More info and screens

0

5. Dividend

5.1 Amount

PIII does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

P3 HEALTH PARTNERS INC

NASDAQ:PIII (7/31/2025, 8:00:00 PM)

7.42

+0.12 (+1.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-05 2025-08-05
Inst Owners11.57%
Inst Owner Change-2.18%
Ins Owners3.68%
Ins Owner Change0%
Market Cap53.35M
Analysts80
Price Target14.62 (97.04%)
Short Float %2.11%
Short Ratio5.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-167.67%
Min EPS beat(2)-366.28%
Max EPS beat(2)30.94%
EPS beat(4)1
Avg EPS beat(4)-267.5%
Min EPS beat(4)-658.17%
Max EPS beat(4)30.94%
EPS beat(8)3
Avg EPS beat(8)-141.81%
EPS beat(12)5
Avg EPS beat(12)-99.64%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-3.87%
Max Revenue beat(2)2.11%
Revenue beat(4)1
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-3.87%
Max Revenue beat(4)2.11%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-44.87%
PT rev (3m)-47.88%
EPS NQ rev (1m)14.25%
EPS NQ rev (3m)-4113.33%
EPS NY rev (1m)29.89%
EPS NY rev (3m)32.49%
Revenue NQ rev (1m)1.11%
Revenue NQ rev (3m)2.43%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)1.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-44.78
EYN/A
EPS(NY)-4.75
Fwd EYN/A
FCF(TTM)-17.19
FCFYN/A
OCF(TTM)-17.19
OCFYN/A
SpS206.56
BVpS8.8
TBVpS-68.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.56%
ROE -217.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.29%
ROA(5y)-20.52%
ROE(3y)-1599.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.89
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z -0.77
F-Score3
WACC10.68%
ROIC/WACCN/A
Cap/Depr(3y)1.55%
Cap/Depr(5y)81.99%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.5%
EPS Next Y64.09%
EPS Next 2Y37.76%
EPS Next 3Y26.06%
EPS Next 5YN/A
Revenue 1Y (TTM)9.78%
Revenue growth 3Y33.03%
Revenue growth 5Y59.38%
Sales Q2Q%-3.93%
Revenue Next Year-4.81%
Revenue Next 2Y1.36%
Revenue Next 3Y1.77%
Revenue Next 5YN/A
EBIT growth 1Y-88.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.32%
EBIT Next 3Y27.3%
EBIT Next 5YN/A
FCF growth 1Y0.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.32%
OCF growth 3YN/A
OCF growth 5YN/A